[Prognostic factors and improving treatment of cutaneous melanoma].
Vihinen
Pia
P
TYKS:n syöpätautien klinikka, Turku. pia.vihinen@tyks.fi
Kähäri
Veli-Matti
VM
Pyrhönen
Seppo
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005387:Finland; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011379:Prognosis; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D013514:Surgical Procedures, Operative / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome